SUBJECTS : Cardiology | Vascular Medicine | Circulatory Disorders | Cardiac Condition
Therapeutic Advances in Cardiovascular Disease: 2021, vol: 15, issue:
- 1)- Jonathan Urbach, Steven R Goldsmith. Vasopressin antagonism in heart failure: a review of the hemodynamic studies and major clinical trials. Therapeutic advances in cardiovascular disease. 2021, 15: 1753944720977741
Cited : 17Read More - 2)- Hataw Al-Taesh, Abuzer Çelekli, Murat Sucu, Seyithan Taysi. Trace elements in patients with aortic valve sclerosis. Therapeutic advances in cardiovascular disease. 2021, 15: 1753944720985985Cited : 0Read More
- 3)- Michael V Genuardi, Paul J Mather. The dawn of the four-drug era? SGLT2 inhibition in heart failure with reduced ejection fraction. Therapeutic advances in cardiovascular disease. 2021, 15: 17539447211002678Cited : 9Read More
- 4)- Michael L Williams, Mathew P Doyle, Nicholas McNamara, Daniel Tardo, Manish Mathew, Benjamin Robinson. Epidemiology of infective endocarditis before after change of international guidelines: a systematic review. Therapeutic advances in cardiovascular disease. 2021, 15: 17539447211002687Cited : 33Read More
- 5)- Bolanle M Soyombo, Ashley Taylor, Christopher Gillard, Candice Wilson, Janel Bailey Wheeler. Impact of body mass index on 90-day warfarin requirements: a retrospective chart review. Therapeutic advances in cardiovascular disease. 2021, 15: 17539447211012803Cited : 3Read More
- 6)- Ishwarlal Jialal, Naval Vikram. Modulating inflammation to reduce atherosclerotic cardiovascular events: should colchicine be part of the therapeutic regimen? Therapeutic advances in cardiovascular disease. 2021, 15: 17539447211042714Cited : 0Read More
- 7)- Ahmed M Shafter, Kashif Shaikh, Amit Johanis, Matthew J Budoff. De-risking primary prevention: role of imaging. Therapeutic advances in cardiovascular disease. 2021, 15: 17539447211051248Cited : 2Read More
- 8)- Trishna Acherjee, Aparna Behara, Muhammad Saad, Timothy J Vittorio. Mechanisms and management of prothrombotic state in COVID-19 disease. Therapeutic advances in cardiovascular disease. 2021, 15: 17539447211053470Cited : 15Read More
- 9)- Biswadeep Das, Saravana Kumar Ramasubbu, Akash Agnihotri, Barun Kumar, Vikram Singh Rawat. Leading 20 drug-drug interactions, polypharmacy, and analysis of the nature of risk factors due to QT interval prolonging drug use and potentially inappropriate psychotropic use in elderly psychiatry outpatients. Therapeutic advances in cardiovascular disease. 2021, 15: 17539447211058892Cited : 11Read More
